Infants at Risk for Aluminum Toxicity with Unapproved Potassium Phosphates Drug Product
Audience: Consumers February 9, 2023 — FDA is warning health care professionals and pharmacies to avoid using Hospira’s unapproved potassium phosphates drug product in pediatric patients because the aluminum exposure from this product is unsafe for this population. This product alone may produce daily aluminum exposures of up to twice the FDA-recommended limit for parenteral […]
EzriCare artificial tears may be contaminated, FDA warns consumers not to buy or use them.
Feb 3, 2023 Due to a potential bacterial contamination, the FDA is advising consumers and healthcare professionals not to purchase and to cease using EzriCare or Delsam Pharma’s artificial tears right once. Using tainted artificial tears raises the risk of eye infections, which can be fatal or cause blindness. Patients who exhibit symptoms of an […]